Neelam Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Neelam Jain has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Kevin R. Krull
Department of Psychology, University of Houston, Houston, Texas
2 shared publicationsPim Brouwers
Department of Pediatrics, Baylor College of Medicine, Houston, Texas
2 shared publicationsM. Fatih Okcu
Department of Pediatrics, Baylor College of Medicine, Houston, Texas
1 shared publicationMurali M. Chintagumpala
Department of Pediatrics, Baylor College of Medicine, Houston, Texas
1 shared publication- Paul T. Cirino
University of Houston, TX, USA
1 shared publication Shiao Y. Woo
Department of Radiation Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, Texas
1 shared publication
Latest Publications
- Open Access
Sex‐specific attention problems in long‐term survivors of pediatric acute lymphoblastic leukemia
BACKGROUND: Neurocognitive problems are a frequent outcome of chemotherapy for pediatric leukemia, although individual differences exist in patient outcome. Sex of the patient and age at diagnosis are 2 characteristics that have been associated with differential outcomes. The relation between these patient characteristics and specific attention deficits (ie, initiating, inhibiting, shifting, focusing, sustaining attention, and working memory) has not been well researched. The purpose of this study was to evaluate the pattern of attention problems in male and female long‐term survivors of pediatric acute lymphoblastic leukemia (ALL).METHODS: One hundred three long‐term survivors (ie, ≥5 years from diagnosis; 51% boys, mean age at diagnosis of 3.9 years, and mean time since diagnosis 7.5 years) completed standardized measures of basic and complex attention skills related to anterior (ie, inhibition, shifting attention, working memory), posterior (ie, focusing), and subcortical brain systems (ie, sustaining).RESULTS: Treatment intensity was related to sustained attention, with those patients treated on high‐risk protocols displaying significantly lower performance. Girls performed worse than boys on measures related to the anterior attention system (ie, shifting attention, P < .042) and the subcortical attention system (ie, sustained attention, P < .001), whereas boys performed worse than girls on different measures of anterior control (ie, inhibition, P < .039; working memory, P < .003).CONCLUSIONS: The results of this study suggest that children diagnosed with and treated for pediatric ALL perform poorly on select measures of attention and executive control, and that this performance is influenced by sex and treatment intensity. Cancer 2009. © 2009 American Cancer Society.
Open AccessSex‐specific attention problems in long‐term survivors of pediatric acute lymphoblastic leukemia
BACKGROUND: Neurocognitive problems are a frequent outcome of chemotherapy for pediatric leukemia, although individual differences exist in patient outcome. Sex of the patient and age at diagnosis are 2 characteristics that have been associated with differential outcomes. The relation between these patient characteristics and specific attention deficits (ie, initiating, inhibiting, shifting, focusing, sustaining attention, and working memory) has not been well researched. The purpose of this study was to evaluate the pattern of attention problems in male and female long‐term survivors of pediatric acute lymphoblastic leukemia (ALL).METHODS: One hundred three long‐term survivors (ie, ≥5 years from diagnosis; 51% boys, mean age at diagnosis of 3.9 years, and mean time since diagnosis 7.5 years) completed standardized measures of basic and complex attention skills related to anterior (ie, inhibition, shifting attention, working memory), posterior (ie, focusing), and subcortical brain systems (ie, sustaining).RESULTS: Treatment intensity was related to sustained attention, with those patients treated on high‐risk protocols displaying significantly lower performance. Girls performed worse than boys on measures related to the anterior attention system (ie, shifting attention, P < .042) and the subcortical attention system (ie, sustained attention, P < .001), whereas boys performed worse than girls on different measures of anterior control (ie, inhibition, P < .039; working memory, P < .003).CONCLUSIONS: The results of this study suggest that children diagnosed with and treated for pediatric ALL perform poorly on select measures of attention and executive control, and that this performance is influenced by sex and treatment intensity. Cancer 2009. © 2009 American Cancer Society.
- 17 April 2008
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (2) , 275-279
Neuropsychological outcome following intensity‐modulated radiation therapy for pediatric medulloblastoma
Background Combined cisplatin chemotherapy and cranial irradiation for treatment of medulloblastoma in children can cause significant ototoxicity and impair cognitive function and quality of life. We have previously demonstrated the conformal technique of intensity‐modulated radiation therapy (IMRT) to reduce ototoxicity, however, it has been suggested that IMRT may increase risk of cognitive deficits compared to conventional radiation therapy (CRT). This study compared the impact of the two treatments on measures of neurocognitive functioning. Procedure Twenty‐five pediatric patients with medulloblastoma were treated either with CRT or IMRT. In addition they received neurocognitive assessments to evaluate long‐term functional outcome. Statistical analyses between the two groups were conducted to compare levels and profiles of performance on tests not confounded with hearing loss. Results When compared to CRT, children treated with IMRT did not perform more poorly on any of the measures. Both groups' mean performance was significantly lower than published norms on several of the measures employed. Conclusion The benefit of reduced ototoxicity with IMRT does not appear to be at the cost of a decline in nonverbal intellectual abilities, visual‐spatial skills, processing speed, or fine motor dexterity when compared to CRT in children with medulloblastoma. Pediatr Blood Cancer 2008;51:275–279.
- 17 April 2008
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (2) , 275-279
Neuropsychological outcome following intensity‐modulated radiation therapy for pediatric medulloblastoma
Background Combined cisplatin chemotherapy and cranial irradiation for treatment of medulloblastoma in children can cause significant ototoxicity and impair cognitive function and quality of life. We have previously demonstrated the conformal technique of intensity‐modulated radiation therapy (IMRT) to reduce ototoxicity, however, it has been suggested that IMRT may increase risk of cognitive deficits compared to conventional radiation therapy (CRT). This study compared the impact of the two treatments on measures of neurocognitive functioning. Procedure Twenty‐five pediatric patients with medulloblastoma were treated either with CRT or IMRT. In addition they received neurocognitive assessments to evaluate long‐term functional outcome. Statistical analyses between the two groups were conducted to compare levels and profiles of performance on tests not confounded with hearing loss. Results When compared to CRT, children treated with IMRT did not perform more poorly on any of the measures. Both groups' mean performance was significantly lower than published norms on several of the measures employed. Conclusion The benefit of reduced ototoxicity with IMRT does not appear to be at the cost of a decline in nonverbal intellectual abilities, visual‐spatial skills, processing speed, or fine motor dexterity when compared to CRT in children with medulloblastoma. Pediatr Blood Cancer 2008;51:275–279.